HCPCS Level II code E2502 represents a speech-generating device (SGD) that uses digitized, pre-recorded messages with recording capacity greater than 8 minutes and up to 20 minutes. These devices are a subset of augmentative and alternative communication (AAC) technologies used to support individuals with complex communication needs resulting from conditions such as neurologic injury, developmental disability, or progressive disease. Nationally, SGDs coded under E2502 are important for access to communication, independence, and participation in education, employment, and community life.

Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical context, typical sites of service, and common billing considerations. The publication outlines benchmarking points, common modifier usage and billing practice notes where available, and highlights policy and coverage themes that affect national access to these devices.

This summary provides a concise guide to what E2502 covers, which payers are typically involved, and what topics the full publication will address, including reimbursement benchmarks, documentation expectations, and clinical considerations for device selection and provision. Data not available in the input will be noted in relevant sections of the full publication.